QUEST PATENT RESEARCH CORP Annual Report - How They Did This Year

I’m putting together a plain-English guide to help you understand how Quest Patent Research Corp (QPRC) performed this year. My goal is to break down their complex filings so you can decide if this company fits your investment strategy.

1. What does this company do?

Quest is a "patent middleman." They don’t make products. Instead, they buy groups of patents and try to make money by licensing them to other companies or suing those they believe are using their technology without permission. Their business model relies entirely on winning legal battles. They focus on semiconductor, data storage, and telecommunications technology.

2. Financial performance: The "Waterfall" reality

The big news this year is a major financing deal from April 2025. To fund operations and buy over 2,500 patents from Monterey Research, they took on significant outside debt.

Because of their "waterfall" payment structure, the money from legal settlements doesn't go straight to their bank account. It goes to their lenders first.

• The 2025 Snapshot: They secured a $19.5 million facility from "QPRC Finance." By the end of 2025, they had already borrowed $1.5 million for basic costs and over $4 million for legal fees.
• The Bottom Line: They are effectively "renting" the money to run these lawsuits. They only keep a small slice of the pie after lenders get their investment and profit back. For the year ending December 31, 2025, the company reported almost no regular income. Their cash flow depends entirely on winning lawsuits and paying off their debt.

3. Major wins and challenges

The company is betting everything on the Monterey Research portfolio. This is a massive gamble; they depend entirely on these specific patents holding up in court. They face "Inter Partes Review" proceedings, where defendants try to cancel their patents. If the Patent Trial and Appeal Board agrees with the defendants, the company’s core assets could become worthless overnight.

4. Financial health

The company has a "working capital deficiency." They have no full-time employees other than their CEO, relying instead on outside lawyers and contractors. They do not generate enough cash to buy new patents or pay legal bills, which is why they rely on high-interest loans. Their ability to stay in business depends entirely on their ability to keep borrowing from their $19.5 million credit line.

5. Key risks for you

• The "All-or-Nothing" Gamble: Revenue comes only from lawsuits. If they lose a case, they lose the potential payout and still owe millions in borrowed money.
• The Lender's Priority: In the "waterfall" system, lenders get paid first. By the time they take their principal, interest, and success fees, there may be very little left for shareholders.
• Funding Dependence: If lenders stop the cash flow, the company stops working. They lack the cash to fund even one major trial on their own.
• Dilution Risk: Because they lack regular income, they may issue more shares to pay debts or buy patents. This reduces your ownership percentage and the value of your shares.

Bottom line: This is a high-risk, speculative play. You aren't investing in a company that makes products; you are betting on the outcome of lawsuits. Creditors, not shareholders, are the primary winners of any successful legal outcome. Before investing, ask yourself if you are comfortable with a business model where the company's survival is tied to the unpredictable nature of patent litigation and the strict repayment terms of their lenders.